Table 1.
Characteristics of respondents in Wave 1 of the PATH.
| Recency of marijuana use |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (N/n, Weighted %) |
Total sample (N = 5,363, 100%) |
Never (n = 2,132, 61.5) |
More than a year ago (n = 1,669, 21.8) |
Within the past year (n = 462, 5.8) |
Within the past 30 days (n = 1,086, 10.9) |
P-value |
|||||
| N | Weighted % | n | Weighted % | n | Weighted % | n | Weighted % | n | Weighted % | ||
| Median age (IQR) | 38 (27, 53) | 43 (29, 56) | 37 (28, 50) | 26 (21, 38) | 28 (21, 39) | <0.001 | |||||
| Sex | <0.001 | ||||||||||
| Male | 2976 | 50.7 | 1057 | 44.3 | 952 | 58.9 | 279 | 56.3 | 680 | 67.3 | |
| Female | 2385 | 49.3 | 1073 | 55.7 | 717 | 41.1 | 183 | 43.7 | 406 | 32.7 | |
| Race/ethnicity | <0.001 | ||||||||||
| Non-Hispanic White | 3193 | 63.0 | 1235 | 60.8 | 1123 | 71.8 | 273 | 67.0 | 552 | 55.6 | |
| Non-Hispanic Black | 757 | 13.1 | 273 | 11.7 | 178 | 11.5 | 74 | 15.5 | 232 | 22.7 | |
| Hispanic | 941 | 17.3 | 441 | 20.4 | 232 | 10.9 | 76 | 13.0 | 188 | 14.3 | |
| Others | 408 | 6.6 | 155 | 7.1 | 119 | 5.6 | 34 | 4.5 | 100 | 7.4 | |
| Educational attainment | 0.070 | ||||||||||
| Less than high school/GED | 1339 | 20.0 | 535 | 19.4 | 376 | 18.8 | 102 | 19.1 | 324 | 26.2 | |
| High school graduate | 1306 | 27.0 | 590 | 28.9 | 362 | 24.3 | 100 | 24.7 | 253 | 22.8 | |
| Some college/AA/College degree or more | 2703 | 53.0 | 1001 | 51.7 | 929 | 56.9 | 260 | 56.2 | 505 | 51.0 | |
| Anti-inflammatory medication use¶ | 0.127 | ||||||||||
| No | 1318 | 23.1 | 564 | 23.6 | 348 | 20.5 | 97 | 20.0 | 307 | 26.8 | |
| Yes | 4028 | 76.9 | 1557 | 76.4 | 1320 | 79.5 | 365 | 80.0 | 776 | 73.2 | |
| Alcohol use in the past 12 months | <0.001 | ||||||||||
| Never/none | 1531 | 37.4 | 941 | 49.8 | 397 | 23.7 | 48 | 7.2 | 143 | 11.5 | |
| Yes | 3815 | 62.6 | 1184 | 50.2 | 1270 | 76.3 | 414 | 92.8 | 940 | 88.5 | |
| Smoking | <0.001 | ||||||||||
| Never/none | 2147 | 63.8 | 1212 | 82.1 | 492 | 37.1 | 163 | 40.8 | 277 | 27.4 | |
| More than 3 days, but within the past yr. | 307 | 3.2 | 83 | 1.7 | 116 | 6.0 | 33 | 5.2 | 74 | 5.3 | |
| Within the past 3 days | 2908 | 33.0 | 837 | 16.2 | 1061 | 56.9 | 266 | 54.0 | 734 | 67.3 | |
| Illicit drug use† | <0.001 | ||||||||||
| No | 5002 | 96.8 | 2109 | 99.8 | 1614 | 97.6 | 410 | 92.0 | 861 | 81.0 | |
| Yes | 315 | 3.2 | 9 | 0.2 | 40 | 2.4 | 51 | 8.0 | 215 | 19.0 | |
| Median BMI (IQR) | 26 (23, 30) | 27 (23, 30) | 26 (23, 30) | 25 (22, 29) | 25 (22, 29) | <0.001 | |||||
Note: PATH = Population Assessment of Tobacco use and Health.
¶Includes aspirin, Tylenol (acetaminophen), Cox-2 inhibitors, ibuprofen, Motrin, Advil, Naprosyn and Aleve; †Includes cocaine/crack, methamphetamine/speed, heroin, inhalants, solvents or hallucinogens in the 12 months; BMI=Body mass index, AA = Associated Degree.